Oncología radioterápica

2022

1. A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression

   Cancers, Vol. 14, Núm. 15

2. A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression

   Practical Radiation Oncology, Vol. 12, Núm. 4, pp. 354-362

3. Bone health and therapeutic agents in advanced prostate cancer

   Frontiers in Bioscience - Landmark, Vol. 27, Núm. 1

4. Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study

   Neurourology and Urodynamics, Vol. 41, Núm. 8, pp. 1824-1833

5. Evaluation of results and costs of high precision radiotherapy (VMAT) compared with conventional radiotherapy (3D) in the treatment of cancer patients with spinal cord compression of metastatic origin

   Reports of Practical Oncology and Radiotherapy, Vol. 27, Núm. 4, pp. 610-614

6. Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy

   Radiation Oncology, Vol. 17, Núm. 1

7. Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02)

   BMC Cancer, Vol. 22, Núm. 1

8. Investigation on the impact of the leaf trailing effect using the Halcyon integrated platform system

   Medical Physics, Vol. 49, Núm. 9, pp. 6161-6170

9. MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial

   British Journal of Radiology, Vol. 95, Núm. 1131, pp. 1-7

10. OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized clinical trial

    Radiotherapy and Oncology, Vol. 176, pp. 76-82

11. Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial

    Radiotherapy and Oncology, Vol. 172, pp. 1-9

12. Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer

    Frontiers in Oncology, Vol. 12

13. Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials

    Cancers, Vol. 14, Núm. 10

14. Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy

    Reports of Practical Oncology and Radiotherapy, Vol. 27, Núm. 3, pp. 428-439

15. Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus

    Radiotherapy and Oncology, Vol. 176, pp. 199-207

16. SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis

    Clinical and Translational Oncology, Vol. 24, Núm. 2, pp. 215-226

17. Should brachytherapy be added to external beam radiotherapy for prostate cancer?

    The Lancet Oncology, Vol. 23, Núm. 1, pp. 23-25